Regulations
CDC, Workplace safety and Health, NIOSH Alert Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings
USP General Chapter 800 Hazardous Drugs – Handling in Healthcare Settings
USP General Chapter 797 Pharmaceutical Compounding – Sterile Preparations
Oncology Nursing Society (ONS)
Preventing occupational exposure to cytotoxic and other hazardous drugs European Policy Recommendations
International Society of Oncology Pharmacy Practitioners (ISOPP)
American Society of Health-System Pharmacists (ASHP)
Papers
In Press
“Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs.” / conducted by Syliva Bartel, Tim Tyler and Luci Power.
Hosp Pharm. | 2020
Evaluating Six Commercially Available Closed-System Drug-Transfer Devices Against NIOSH’s 2015 Draft Vapor Protocol
J Occup Environ Med | 2010
Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers
Am J Health Syst Pharm | 2006
Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques
Internal White Papers
Using HALO for the prevention of microbial ingress.
Internal White Papers
Drug resistance of materials used in HALO Closed System Transfer Device.
Internal White Papers
Pressure test of HALO Closed System Transfer Device.
Internal White Papers
A comparative test for fluid containment between HALO and BD PhaSeal® Closed System Transfer Devices.
Internal White Papers